Lars Iversen

17.7k total citations · 2 hit papers
315 papers, 11.8k citations indexed

About

Lars Iversen is a scholar working on Immunology, Dermatology and Molecular Biology. According to data from OpenAlex, Lars Iversen has authored 315 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 169 papers in Immunology, 106 papers in Dermatology and 63 papers in Molecular Biology. Recurrent topics in Lars Iversen's work include Psoriasis: Treatment and Pathogenesis (119 papers), Dermatology and Skin Diseases (59 papers) and Cutaneous lymphoproliferative disorders research (37 papers). Lars Iversen is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (119 papers), Dermatology and Skin Diseases (59 papers) and Cutaneous lymphoproliferative disorders research (37 papers). Lars Iversen collaborates with scholars based in Denmark, United States and United Kingdom. Lars Iversen's co-authors include Claus Johansen, Knud Kragballe, Jos Kielgast, Philip Francis Thomsen, Morten Rasmussen, Eske Willerslev, Lone Skov, Robert Gniadecki, Peter Rask Møller and Ludovic Orlando and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Lars Iversen

306 papers receiving 11.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Monitoring endangered freshwater biodiversity using environmental DNA

2011 892 citations Philip Francis Thomsen, Lars Iversen et al. profile →
Detection of a Diverse Marine Fish Fauna Using Environmental DNA from Seawater Samples

2012 755 citations Philip Francis Thomsen, Lars Iversen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lars Iversen Denmark	55	4.9k	3.5k	3.3k	1.7k	1.3k	315	11.8k
William Cookson United Kingdom	62	3.8k 0.8×	7.3k 2.1×	2.1k 0.6×	682 0.4×	601 0.5×	191	21.7k
Maria L. Turner United States	50	2.3k 0.5×	4.8k 1.4×	4.6k 1.4×	212 0.1×	1.4k 1.1×	126	14.1k
Kevin D. Cooper United States	70	6.3k 1.3×	2.1k 0.6×	6.4k 1.9×	187 0.1×	1.5k 1.2×	355	14.8k
Wenqing Li China	55	2.4k 0.5×	3.7k 1.1×	1.6k 0.5×	153 0.1×	1.7k 1.3×	377	11.2k
Peter C. Taylor United Kingdom	71	4.4k 0.9×	2.8k 0.8×	717 0.2×	167 0.1×	2.5k 1.8×	450	17.6k
Kari C. Nadeau United States	72	4.1k 0.8×	2.5k 0.7×	2.0k 0.6×	98 0.1×	669 0.5×	452	19.0k
Margaret R. Karagas United States	77	762 0.2×	7.1k 2.1×	2.0k 0.6×	212 0.1×	2.7k 2.0×	490	21.6k
Ana M. Valdes United Kingdom	68	2.0k 0.4×	7.1k 2.0×	263 0.1×	676 0.4×	868 0.7×	308	19.8k
Véronique Bouvard France	41	769 0.2×	2.2k 0.6×	665 0.2×	603 0.4×	3.0k 2.3×	60	14.9k
Masutaka Furue Japan	64	4.2k 0.9×	3.2k 0.9×	8.0k 2.4×	56 0.0×	2.0k 1.5×	741	17.3k

Countries citing papers authored by Lars Iversen

Since Specialization

Citations

This map shows the geographic impact of Lars Iversen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Iversen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Iversen more than expected).

Fields of papers citing papers by Lars Iversen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Iversen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Iversen. The network helps show where Lars Iversen may publish in the future.

Co-authorship network of co-authors of Lars Iversen

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Iversen. A scholar is included among the top collaborators of Lars Iversen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Iversen. Lars Iversen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pedersen, Martin Bjerregård, et al.. (2025). Systemic Targeted Therapies in Patients with Relapsed/Refractory Advanced Stage Cutaneous T-cell Lymphoma: A Real-world Single-centre Case Series. Acta Dermato Venereologica. 105. adv40952–adv40952.

Gyldenløve, Mette, Claus Zachariae, Alexander Egeberg, et al.. (2025). Oral Roflumilast Suppresses Proinflammatory Cytokine Signaling and Reduces CD4+ T-Cell and Neutrophil Infiltration in Psoriasis. Journal of Investigative Dermatology. 145(12). 3079–3088.e3.

Zachariae, Claus, Jakob Benedict Seidelin, Susanne Dam Nielsen, et al.. (2025). Adverse Events and Immune Response in Psoriasis Patients Receiving Interleukin-17 Inhibitors. Acta Dermato Venereologica. 105. adv43685–adv43685. 1 indexed citations

Hjuler, Kasper Fjellhaugen, et al.. (2024). On the Interdisciplinary Treatment and Management of Patients with Immune-Mediated Inflammatory Diseases. A Study on Patients’ Personal Experiences and Perspectives. Journal of Multidisciplinary Healthcare. Volume 17. 2635–2646.

Bertelsen, Trine, et al.. (2024). ERAP1 and ERAP2 gene variants as potential clinical biomarkers of anti-interleukin-17A response in psoriasis vulgaris. Clinical and Experimental Dermatology. 49(10). 1171–1178. 3 indexed citations

Bendixen, Mette, et al.. (2024). Towards a holistic understanding of artisanal aggregate mining in Rwanda. The Extractive Industries and Society. 19. 101471–101471. 2 indexed citations

Nikamo, Pernilla, Leena Laasonen, Björn Guðbjörnsson, et al.. (2024). Rare coding variants in NOX4 link high ROS levels to psoriatic arthritis mutilans. EMBO Molecular Medicine. 16(3). 596–615. 5 indexed citations

Torres, Tiago, Jordi Galván, Lars Iversen, et al.. (2023). Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review. Dermatology and Therapy. 13(10). 2153–2169. 3 indexed citations

Lebwohl, Mark, Lars Iversen, Liv Eidsmo, et al.. (2023). Investigation of plaque psoriasis relapse after secukinumab withdrawal in patients from two phase III studies. Clinical and Experimental Dermatology. 49(8). 793–800. 10 indexed citations

10.

Steiniche, Torben, et al.. (2022). Climatotherapy at the Dead Sea for psoriasis is a highly effective anti‐inflammatory treatment in the short term: An immunohistochemical study. Experimental Dermatology. 31(8). 1136–1144. 11 indexed citations

11.

Bygum, Anette, Lone Skov, M. Sachs, et al.. (2021). Establishment of a Nationwide Patient Database for Clinical Trial Recruitment in Dermatology: Concept and Patient Characteristics. Acta Dermato Venereologica. 101(5). adv00461–adv00461. 1 indexed citations

12.

Bregnhøj, Anne, Thomas Litman, Christina L. Grek, et al.. (2021). HSP90 inhibitor RGRN‐305 for oral treatment of plaque‐type psoriasis: efficacy, safety and biomarker results in an open‐label proof‐of‐concept study*. British Journal of Dermatology. 186(5). 861–874. 29 indexed citations

13.

Iversen, Lars, et al.. (2020). Calcipotriol/Betamethasone Dipropionate Cutaneous Foam Treatment for Psoriasis in Patients With BSA 5–15% and PGA ≥ 3: Post-Hoc Analysis From Three Randomized Controlled Trials. Dermatology and Therapy. 10(5). 1111–1120. 4 indexed citations

14.

Buus, Terkild B., Andreas Willerslev-Olsen, Simon Fredholm, et al.. (2018). Single-cell heterogeneity in Sézary syndrome. Blood Advances. 2(16). 2115–2126. 74 indexed citations

15.

Danielsen, Karen Vagner, Lars Iversen, Mikkel Østergaard, et al.. (2018). Prevalence of Psoriasis and Psoriatic Arthritis and Patient Perceptions of Severity in Sweden, Norway and Denmark: Results from the Nordic Patient Survey of Psoriasis and Psoriatic Arthritis. Acta Dermato Venereologica. 99(1). 0–0. 28 indexed citations

16.

Willerslev-Olsen, Andreas, Thorbjørn Krejsgaard, Lise M. Lindahl, et al.. (2016). Staphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphoma. Blood. 127(10). 1287–1296. 77 indexed citations

17.

Enghoff, Henrik, et al.. (2011). Tusindben, skolopendre og mejere fra Rødbyhavn og omegn – med fem nye arter for den danske fauna (Diplopoda, Chilopoda, Opiliones). Research at the University of Copenhagen (University of Copenhagen). 79. 3–12. 2 indexed citations

18.

Bertelsen, Trine, Lars Iversen, Jette Lindorff Riis, et al.. (2010). The role of mitogen‐ and stress‐activated protein kinase 1 and 2 in chronic skin inflammation in mice. Experimental Dermatology. 20(2). 140–145. 20 indexed citations

19.

Johansen, Claus, et al.. (2000). AP-1 DNA binding activity is significantly reduced in involved psoriatic skin In vitro and in vivo regulation of AP-1 DNA binding activity by 1alpha,25 2D3 and calcipotriol. Journal of Investigative Dermatology. 115(3). 534. 1 indexed citations

20.

Tønnesen, Hanne, et al.. (2000). [Active and passive smoking among personnel at the Bispebjerg Hospital 1992-1999].. PubMed. 162(42). 5623–7. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact